P&G Snaps Up Thorne for $3.8 Billion Wellness Play

Procter & Gamble (P&G) is acquiring Thorne in a $3.8 billion cash deal, marking a significant investment in the science-backed wellness sector.

The acquisition follows L Catterton's investment in Thorne in 2023, during which the firm supported the brand's expansion through leadership appointments and increased investment in science and R&D, manufacturing, digital capabilities, and AI-powered consumer tools.

Thorne specializes in vitamins, minerals, and supplements, and has strengthened its practitioner relationships and developed a proprietary AI wellness advisor. The transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions.